Urological tumors, including prostate cancer and urothelial carcinomas, remain major contributors to global cancer morbidity and mortality. Despite recent ...

Nadine and David Lipworth have devoted their lives to finding treatment that will restore the daughter they knew.

As genome editing therapies move through clinical trials to regulatory approval, scientists continue the quest for the holy ...

In cancer research, one person's junk is increasingly becoming another person's treasure. Scientists have now uncovered new evidence showing how recently evolved "junk DNA" genetic elements can become ...

ASCO 2026 highlighted a shift toward precision-driven oncology R&D, where biomarkers, ctDNA, and integrated strategies guide ...

Inherited retinal degenerations are a diverse group of genetic disorders that result in progressive vision loss. Advances in ...

Researchers reviewed 23 trials of melatonin for pain. It reduced chronic pain and improved sleep, with effects comparable to ...

Minimally disruptive genetic code expansion enables faithful, site-specific labeling of G3BP1 and TDP-43, revealing native stress granule dynamics and ALS-linked protein behavior in live cells.

Mar. 27, 2026 Scientists have uncovered a hidden reason why cancer treatments don’t work equally well for everyone. Certain drugs can become trapped inside lysosomes within tumor cells, forming ...